Mutations activating proliferation pathways in ovarian cancer

被引：0
|
作者：
Uhrhammer, Nancy A. [1 ]
Bidet, Yannick [2 ]
Chene, Gautier [1 ]
Viala, Sandrine [1 ]
Communal, Yves [1 ]
Raoelfils, Ines [1 ]
Penault-Llorca, Frederique [1 ]
Bignon, Yves-Jean [1 ]
机构：
[1] Ctr Jean Perrin, Clermont Ferrand, France
[2] Univ Auvergne, Clermont Ferrand, France
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4854
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4854
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy
    Li, Ruli
    Li, He
    Lan, Jie
    Yang, Dongmei
    Lin, Xinjing
    Xu, Hongling
    Han, Bin
    Yang, Ming
    Su, Bo
    Liu, Fu
    Jiang, Wei
    PHYTOMEDICINE, 2022, 100
  • [22] Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer
    YingYing He
    Zhicheng He
    Xiaoyu Zhang
    Shubai Liu
    Cancer Cell International, 21
  • [23] Platelet-activating factor acetyl hydrolase IB2 dysregulated cell proliferation in ovarian cancer
    He, YingYing
    He, Zhicheng
    Zhang, Xiaoyu
    Liu, Shubai
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [24] Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways
    Zhang, Jianxin
    Wang, Fengchun
    Wang, Huali
    Wang, Yanna
    Wu, Yan
    Xu, Hui
    Su, Chen
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (06) : 5445 - 5451
  • [25] FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3
    Tao, Xiang
    Zhao, Naiqing
    Jin, Hongyan
    Zhang, Zhenbo
    Liu, Yintao
    Wu, Jian
    Bast, Robert C., Jr.
    Yu, Yinhua
    Feng, Youji
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : 415 - 429
  • [26] CBP truncating mutations in ovarian cancer
    Ward, R
    Johnson, M
    Shridhar, V
    van Deursen, J
    Couch, FJ
    JOURNAL OF MEDICAL GENETICS, 2005, 42 (06) : 514 - 518
  • [27] Recurrent ESR1 mutations activating mutations in breast cancer
    Jeselsohn, R.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] Identifying pathways affected by cancer mutations
    Iengar, Prathima
    GENOMICS, 2018, 110 (05) : 318 - 328
  • [29] Serous Ovarian Cancer Signaling Pathways
    Kotsopoulos, Ioannis C.
    Papanikolaou, Alexios
    Lambropoulos, Alexandros F.
    Papazisis, Konstantinos T.
    Tsolakidis, Dimitrios
    Touplikioti, Panagiota
    Tarlatzis, Basil C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (03) : 410 - 417
  • [30] [Advocate Abstract] Pathways to ovarian cancer
    Richardson, Kimberly
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
12345